Hubbell Other Income (Expense) increased by 30.8% to -$5.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.9%, from -$5.30M to -$5.40M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a 67.1% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$1.00M | -$1.20M | $8.50M | $3.60M | $2.50M | $800.00K | -$4.10M | -$4.80M | -$3.50M | -$6.10M | -$700.00K | -$1.20M | -$5.60M | $0.00 | -$5.30M | -$6.20M | -$5.90M | -$7.80M | -$5.40M |
| QoQ Change | — | -20.0% | +808.3% | -57.6% | -30.6% | -68.0% | -612.5% | -17.1% | +27.1% | -74.3% | +88.5% | -71.4% | -366.7% | +100.0% | — | -17.0% | +4.8% | -32.2% | +30.8% |
| YoY Change | — | — | — | — | +350.0% | +166.7% | -213.9% | -292.0% | -537.5% | — | +82.9% | +75.0% | -60.0% | +100.0% | -657.1% | -416.7% | -5.4% | — | -1.9% |